In a first study of its kind, a Brazilian group of researchers have identified the differences among different types of stem cell from different body part. The study has found that the fat collected from the lower abdomen and inner thigh contains more stem cell than the other part of the body. The fat from all these parts are rich in stem cell.

Read the rest of this entry (283 words) »

On 11th July 2008,  Stempeutics Research Private Limited, a group company of Manipal Education and Medical Group(MEMG) opened its second Stem Cell Lab at Manipal University campus.Chief Scientific Officer of Stempeutics Dr Satish Totey, Vice-Chancellor of MU Dr Raj P Warrier, General Manager of Stempeutics N Manjunath and others were present in that auspicious occasion.

Read the rest of this entry (257 words) »

Stem Enhance, a product of Stem tech made by Christian Drapeau , a neurophysiocist and CSO of stem tech health sciences . Inc and his colleague Gitte Jenson is believed to be a breakthrough in the market of health products. It contains all the natural and botanical products that supports the natural release of stem cells. It is the very first product on the market from the latest phytoceutical product category called “stem cell enhancers”.

Read the rest of this entry (343 words) »

The US based Cytori Therapeutics has developed a new device based on the Celution System which will enable the researchers to use the fat tissue of the patients to turn into a regenerative cell cocktail for the use of medical procedures or for future use. Unlike the embryonic stem cell research the procedure is expected to be free from any controversy. Also the process of removing a little unwanted fat from patients is good in itself. The company has been successful in the research procedure so far. The company recorded its first product revenue during 1Q08 of $153,000 related to sales of the Celution System.

Read the rest of this entry (308 words) »

Researchers at the Washington University School of Medicine in St. Louis have found out that mouse embryonic stem cell can be put to work building the heart. Thus the study can be considered as a major significant step to a new generation of treatments that use human stem cells.

Read the rest of this entry (375 words) »

Gabriel Lasala, MD and former staff cardiologist of Byrd Regional Hospital had established a stem cell therapy company, TCA Cellular Therapy in Covington. It is one of the three institutions in the country that are currently treating myocardial infarction and other cardiac problems with the patient’s own stem cells. Also it is the only private company in the United States that is participating in FDA research protocols utilizing adult stem cells. The company is also treating circulatory problems affecting the legs and is currently seeking approval for the treatment of neurologic diseases.

Read the rest of this entry (324 words) »

Scientists at the Children’s Hospital Boston have found previously unrecognized group of stem cells that give rise to cardiomyocytes, or heart muscle cells. It brings the hope of being able to regenerate injured heart tissue. The study was published in the journal Nature on June 22.

Read the rest of this entry (320 words) »

Bio-heart has finally revealed the data of its seismic trial. It shows that Myocell Myoblast clinical cell therapy is good way to improve heart problems like cardiac devices and congested heart diseases. Researchers also say that the treatment is a safe one. The research was conducted with 26 patients receiving Myocell therapy, against 14 patients in control group. All of them were patients of heart disease, receiving standard medical treatment. Six month of trial revealed that almost 84% of the patient were improved.

Read the rest of this entry (119 words) »

Scientists from the University of California Los Angeles claimed to have made heart and blood cells from so-called induced pluripotent stem cells. The iPS cells which are transformed skin cells is believed to have the powers of embryonic stem cells.

Read the rest of this entry (169 words) »

New regulations for the use of the DIY kits will be introduced from July 5 this year. The new law aims to curb the use of DIY kits for collecting blood from umbilical cords. According to the rules issued by the Human Tissue Authority, every hospital and clinic will need a license to ensure that the blood is collected by trained staff following correct procedures. Cord blood, rich in stem cell, can be used in various complicated diseases. Cord blood collected from from a baby’s umbilical cord is stored in liquid nitrogen, for future use. But the growth of private banks, which send out DIY collection kits to couples, has worried medical authorities. The Human Tissue Authority has issued the regulation to make sure of the collected samples as well as the proper procedure of collecting cord blood. It makes sure that each clinic employs the right candidate for the task. Source: THE INDEPENDENT